Profile data is unavailable for this security.
About the company
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
- Revenue in USD (TTM)466.26m
- Net income in USD181.11m
- Incorporated2008
- Employees581.00
- LocationInmode LtdTavor Building, Sha'ar Yokneam, Pob 533YOKNEAM 2069200IsraelISR
- Phone+972 49097470
- Websitehttps://inmodemd.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Artivion Inc | 368.21m | -9.58m | 987.02m | 1.50k | -- | 3.35 | 72.44 | 2.68 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.26 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.09bn | 1.20k | -- | 2.38 | -- | 2.62 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Coretag Inc | 0.00 | -34.52k | 1.13bn | 0.00 | -- | -- | -- | -- | -0.3806 | -0.3806 | 0.00 | -0.9801 | 0.00 | -- | -- | -- | -3,303.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 10.95 | -- | -- | -- |
| MiMedx Group Inc | 334.51m | 71.52m | 1.15bn | 895.00 | 20.62 | 7.36 | 14.39 | 3.43 | 0.3767 | 0.3393 | 2.15 | 1.06 | 1.72 | 2.82 | 6.58 | 373,754.20 | 41.80 | -4.14 | 53.13 | -5.90 | 83.50 | 83.61 | 24.36 | -2.70 | 2.71 | 9.00 | 0.111 | -- | 20.03 | -2.19 | 310.29 | -- | -26.47 | -- |
| Adapthealth Corp | 3.25bn | -695.41m | 1.28bn | 10.70k | -- | 0.8766 | -- | 0.3945 | -5.18 | -5.18 | 24.27 | 10.97 | 0.6637 | 21.66 | 8.30 | 303,555.90 | -14.15 | -4.34 | -15.82 | -4.89 | 18.45 | 18.28 | -21.32 | -6.47 | 1.11 | 2.08 | 0.6025 | -- | 7.73 | -- | -1,169.99 | -- | -- | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.32bn | 13.70k | -- | 1.48 | 5.25 | 0.1268 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Alphatec Holdings Inc | 511.63m | -191.60m | 1.41bn | 839.00 | -- | 38.30 | -- | 2.76 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.46bn | 781.00 | -- | 25.64 | -- | 9.38 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
| Inmode Ltd | 466.26m | 181.11m | 1.56bn | 581.00 | 8.76 | 1.87 | 8.59 | 3.35 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
| LeMaitre Vascular Inc | 199.89m | 33.95m | 1.79bn | 614.00 | 52.72 | 5.79 | 41.07 | 8.94 | 1.51 | 1.51 | 8.89 | 13.74 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| UFP Technologies Inc | 407.33m | 47.88m | 1.89bn | 3.09k | 39.79 | 6.42 | 31.84 | 4.65 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| Premier Inc | 1.34bn | 80.33m | 2.00bn | 2.80k | 29.65 | 1.04 | 10.14 | 1.49 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
| Warby Parker Inc | 697.80m | -55.06m | 2.00bn | 2.14k | -- | 6.31 | -- | 2.86 | -0.467 | -0.467 | 5.91 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
| STAAR Surgical Co | 326.24m | 15.30m | 2.07bn | 1.06k | 136.33 | 5.27 | 100.10 | 6.35 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
| Patterson Companies, Inc. | 6.57bn | 193.86m | 2.13bn | 7.60k | 11.74 | 2.21 | 7.62 | 0.3249 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
Data as of May 23 2024. Currency figures normalised to Inmode Ltd's reporting currency: US Dollar USD
25.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 5.34m | 6.31% |
| Fidelity Investments Canada ULCas of 31 Mar 2024 | 3.40m | 4.02% |
| Meitav Mutual Funds Ltd.as of 31 Mar 2024 | 1.92m | 2.28% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.89m | 2.23% |
| LSV Asset Managementas of 31 Mar 2024 | 1.88m | 2.22% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 1.85m | 2.19% |
| Boston Trust Walden, Inc.as of 31 Mar 2024 | 1.45m | 1.71% |
| DOMA Perpetual Capital Management LLCas of 31 Mar 2024 | 1.18m | 1.40% |
| Menora Mivtachim Insurance Ltd.as of 31 Mar 2024 | 1.17m | 1.39% |
| Manulife Investment Management (US) LLCas of 31 Mar 2024 | 1.11m | 1.31% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
